Shares of Sarepta Therapeutics Inc (SRPT) are soaring in pre-market trade on Friday, gaining as much as 11%. The surge follows the company’s recent announcement regarding the publication of results from two studies that demonstrated no clinical or toxicologic safety concerns with its drug candidates for the treatment of Ebola and Marburg virus, respectively. Sarepta said […]
View the full post at: Morning Buzz: Sarette Therapeutics (SRPT), Repros Therapeutics (RPRX), CytRx Corporation (CYTR), Tesla Motors (TSLA)